KEY, LOCK, and LOCKSMITH: Complementary hydropathic map predictions of drug structure from a known receptor-receptor structure from known drugs

Erlich, 1913, Chemotherapeutics: scientific principles, methods, and results, Lancet, 445 Motoc, 1986, Three-dimensional structure-activity relationships and biological receptor mapping, 221 Marshall, 1987, Computer-aided drug design, Ann. Rev. Pharmacol. Toxicol., 27, 193, 10.1146/annurev.pa.27.040187.001205 Cramer, 1988, Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110, 5959, 10.1021/ja00226a005 Kellogg, 1991, HINT—A new method of empirical hydrophobic field calculation for CoMFA, J. Comput.-Aided Mol. Design., 5, 545, 10.1007/BF00135313 Wireko, 1991, Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors, J. Med. Chem., 34, 758, 10.1021/jm00106a042 Kuntz, 1982, A geometric approach to macromolecule-ligand interactions, J. Mol. Biol., 161, 269, 10.1016/0022-2836(82)90153-X DesJarlais, 1986, Docking flexible ligands to macromolecular receptors by molecular shape, J. Med. Chem., 29, 2149, 10.1021/jm00161a004 DesJarlais, 1988, Docking flexible ligands to macromolecular receptors by molecular shape, J. Med. Chem., 31, 722, 10.1021/jm00399a006 Meyer, 1899, Zur Theorie der Alkoholnarkose. Erste Mittheilung. Welche Eigenschaft Anästhetica bedingt ihrenarkotische Wirkung?, Arch. Exp. Pathol. Pharmakol., 42, 109, 10.1007/BF01834479 Hansch, 1964, ϱ-σ-π analysis. A method for the correlation of biological activity and chemical structure, J. Am. Chem. Soc., 88, 1616, 10.1021/ja01062a035 Akamatsu, 1989, Hydrophobicity of di- and tripeptides having unionizable side chains and correlation with substituent and structural parameters, Quant. Struct.-Act. Relat., 8, 195, 10.1002/qsar.19890080302 Hansch, 1979, 1 Abraham, 1987, Extension of the fragment method to calculate amino acid zwitterion and side chain partition coefficients, Proteins: Struct. Funct. Genetics, 2, 130, 10.1002/prot.340020207 Kellogg, 1992, New Tools for Modeling and Understanding Hydrophobicity and Hydrophobic Interactions, Med. Chem. Res., 1, 444 Fauchere, 1988, Estimating and representing hydrophobicity potential, J. Molec. Graphics, 6, 203, 10.1016/S0263-7855(98)80004-0 Levitt, 1983, Molecular dynamics of native protein. I. Computer simulation of trajectories, J. Mol. Biol., 168, 595, 10.1016/S0022-2836(83)80304-0 Levitt, 1988, Aromatic rings act as hydrogen bond acceptors, J. Mol. Biol., 201, 751, 10.1016/0022-2836(88)90471-8 Allen, 1990, Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site, J. Med. Chem., 33, 2343, 10.1021/jm00171a007 Norinder, 1990, Experimental design based 3-D QSAR analysis of steroid-protein interactions: Application to human CBG complexes, J. Comput.-Aided Mol. Design, 4, 381, 10.1007/BF00117403 Wold, 1978, Cross-validatory estimation of the number of components in factor and principal components models, Technometrics, 20, 397, 10.2307/1267639 Perutz, 1986, Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding, J. Am. Chem. Soc., 108, 1064, 10.1021/ja00265a036 Lalezari, 1988, LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholestrol, and on low density lipoprotein, Proc. Natl. Acad. Sci. U.S.A., 85, 6117, 10.1073/pnas.85.16.6117 Lalezari, 1990, New effectors of human hemoglobin: Structure and function, Biochemistry, 29, 1515, 10.1021/bi00458a024 Available from Tripos Associates, 1699 South Hanley Road St. Louis, Missouri 63144 (USA) Randad, 1991, Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents, J. Med. Chem., 34, 752, 10.1021/jm00106a041 Tanford, 1980, 1 Kollman, 1980, The nature of the drug-receptor bond, 313 Franke, 1984, 1